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Abstract
Background: Chlorhexidine is well known for its antiplaque effect. However, the mouthrinse based chlorhexidine 
antiplaque efficiency may vary according to the formulation of the final product. The aim of the present study 
was to compare anti-plaque effectiveness of two commercial mouthrinses: 0.12 % Chlorhexidine alcohol base 
(CLX-A) versus a diluted 0.1% Chlorhexidine non-alcohol base with 0.1% of Formaldehyde (CLX-F).
Material and Methods: the study was a seven day randomized, double-blind, placebo-controlled trial including 30 
volunteers. At the start, all participants received a dental prophylaxis. Over 7 days experimental non-brushing pe-
riod, during which subjects abstained from all forms of mechanical oral hygiene, one group test rinsed twice daily 
with 15ml of an alcohol base 0.12% Chlorhexidine mouthrinse. The second group test used 15ml of alcohol free 
0.1% Chlorhexidine mouthrinse base 0.1% formaldehyde twice daily. The negative control group used a placebo. 
Plaque indexes were recorded in all volunteers prior to treatment at Day 0, 1 and 7. 
Results: After 7 days, the mean plaque index for the first group was 0.76±0.38 compared with a mean plaque index of 
1.43±0.56 for the second group. The difference in plaque scores between the groups was statistically significant. 
Conclusion: the results of this study showed that rinsing with an alcohol base 0.12% Chlorhexidine mouthrinse is 
significantly different from rinsing with an alcohol free 0.1% Chlorhexidine mouthrinse on plaque inhibition.
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Introduction
Since 1965, dental plaque has been considered to be the 
initiating factor in the development of gingivitis (Loë et 
al, 1965) (1). Therefore, plaque control has been the key-
stone of periodontal diseases’ prevention and treatment. 
Plaque control is based on using toothbrush (manual 
or electric); interdental brushes, floss, and toothpicks. 
These various tools are essential for oral hygiene and 
require a degree of motivation and skill for an effec-
tive and sustained use. In the absence of an adequate 
oral hygiene by mechanical devices, chemical products 
would act as a complementary or in some cases as an 
alternative method (Brecx 1997) (2).
Among antiseptics possessing an anti plaque effect, 
chlorhexidine is certainly the most tested one during 
the last decades. As a result of previous clinical studies, 
0.2 % chlorhexidine mouthrinse (CLX) has become the 
international standard (3-8).
However, because of some side effects associated with 
this agent (tooth staining, taste disturbance), mouthrins-
es with a low level of this agent were proposed. Indeed, 
many studies have demonstrated that 0.1 % and 0.12 % 
CLX mouthrinse have a significant comparable effect 
on plaque reduction as 0.2 % CLX formulation (9-12).
These results showed the importance of the dose effect in-
dependently of the concentration. Therefore, it would seem 
desirable to use a CLX mouthrinse with low concentra-
tion but released in sufficient dose to preserve its action on 
plaque inhibition. Despite the concentration and the dose, 
the formulation of CLX mouthrinses can also influence 
plaque inhibition. Traditionally, CLX mouthrinses include 
alcohol. But, because of adverse effects of this agent, the 
alcohol was removed in some brands.
The aim of the present study was to investigate the effect 
on plaque inhibiting of two CLX mouthrinses: 0.12 % CLX 
alcohol base versus a diluted 0.1 % CLX non-alcohol base 
containing 0.1% of formaldehyde, and a placebo solution.
Material and Methods
-Participants
To detect a minimum effect size of 0.6 (large effect) in 
mean plaque index variation at day 7, with 80% power 
and a two-sided 5% significance level, would require 30 
patients (10 in each group). 
The study included 30 volunteers among healthy dental 
students from the school of dentistry in Rabat, Morocco. 
Students were of both gender and aged 20 to 25 years. They 
were excluded from the study if any of the following were 
present: (1) less than 20 teeth; (2) pre-sence of periodontal 
disease (3) presence of factors of plaque retention (clini-
cally unacceptable restorations, important carious, dental 
overlapping, removable prosthesis, faulty fixed prosthesis, 
orthodontic appliances), (4) associated systemic diseases 
(diabetes, heart disorders, blood diseases, VIH infection), 
(5) use of antibiotics or other anti-inflammatory drugs dur-
ing the  3 latest months, (6) known allergy against compo-
nents of mouth rinses, (7) pregnancy, (8) smoking.
The study was approved by the Ethical Committee of 
Biomedical Research of Mohamed 5 Souissi University, 
Rabat, Morocco (CERB) Ref: 1251/09. 
All recruited students received complete information 
about the study and gave written informed consent be-
fore entering the study.
-Study design
This was a double-blind study with 3 parallel groups 
using 3 different solutions.
Volunteers were randomized to receive for 7 days either 
placebo or chlorhexidine mouthrinse alcohol base or 
Chlorhexidine mouthrinse formaldehyde base.
• The first test group used 15 ml of pure 0.12% CLX 
alcohol base (Group1: 0.12 % CLX-A). 
• The second test group used 15 ml of diluted 0.1 % 
CLX non-alcohol base containing 0.1% of formalde-
hyde (Group2: 0.1 % CLX-F).
• The third control group used 15 ml of a placebo 
(Group3: P). The placebo is a solution containing 0.1g 
vanilla, 1g sorbitol, and water.
Mouthrinses were supplied in coded bottles containing 
125 ml. The placebo was identically supplied.
This clinical trial was including two phases: pre-expe-
rimental period of 14 days, and experimental period of 
7 days.
-Pre-experimental period 
The aim of this phase was to obtain, on Day 0 (the day 
before the start of the experimental period), an oral ca-
vity with low plaque deposits (PI< 1) and from gingival 
bleeding. 
During this period, the volunteers were instructed to estab-
lish and maintain strict oral hygiene. Similar toothbrushes, 
toothpastes, and flosses were given to each one. They also 
received, during two weeks (Day -14 to Day 0), sessions of 
professional mechanical tooth cleaning to remove all vis-
ible plaque, calculus, and extrinsic tooth stain.
Plaque index (PI) was recorded at Day -14 and Day 0.
-Experimental period
A computer-regenerated randomisation list was drawn 
up by the statistician (RA). The dental practitioner 
(AB), responsible for seeing the participants, allocated 
the next available number on entry into the trial, and 
each participant collected his mouthrinse solution from 
the department of periodontology. 
The clinical trial lasted 7 days (from Day 0 to Day 7). 
During this period all participants abstained from all 
mechanical oral hygiene procedures.   
On Day 0, subjects were randomly distributed in three 
groups: two test groups and one negative control group, 
and were instructed to rinse twice daily with the allo-
cated mouthrinse during the experimental period. 
The clinical measurement: Plaque Index (PI) was re-
corded on Day 1 and Day 7.
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On Day 7, all subjects were examined for the presence 
or absence of tooth staining, and were questioned about 
taste disturbances and mucosal sensitivities. 
All measurements were carried out under the same con-
ditions by the same qualified examiner (L.L), who was 
unaware of which mouthrinse was used by which par-
ticipant. The participants were also blinded to the used 
mouthrinse.  
The code was revealed to the periodontal practitioner 
once recruitment and data collection were completed.
-Statistical analysis
The quantitative variables (PI) were expressed on mean 
and standard deviation.
For the quantitative variables, the one way analysis of 
variance (ANOVA) was used for the comparison of the 
3 groups followed by the Turkey test for the multiple 
comparisons between groups. 
The qualitative variables (stains) were compared by the 
Fisher’s exact test.
The level of significance was based on p<0.05.
All statistical analyses were carried out using SPSS for 
windows 13.0 (SPSS, Chicago, IL).
Results
All 30 subjects completed the 7 days rinse period (10 in 
the 0.12% CLX-A group, 10 in the 0.1% CLX-F group 
and 10 in the negative control group).
The mean plaque index (PI) on Day -14, Day 0, Day 1 
and Day 7 is presented in table 1. There were no signifi-
cant differences between the groups on Day -14, Day 0 
and Day 1. But, on Day 7, the CLX-A group was sig-
nificantly different from CLX-F group and the placebo 
group. Indeed, Scores of plaque overgrowth were less 
high with 0.12% CLX-A than with 0.1% CLX-F and pla-
cebo.
The active solutions showed side effects in some sub-
jects. Indeed, 2 participants (20%) complained about 
mouth burning and taste disturbance during and after 
rinsing with the 0.12% CLX solution (alcohol base). All 
side effects disappeared after stopping the mouthrinses 
and resuming daily oral hygiene procedures.
The tooth staining was recorded as present or absent. 
The scores evaluation did not show any significant dif-
ference among the tested product (Group 1 and Group 
2) (Table 2).
0,1%CHX-F
n = 10
0,12%CHX-A
n = 10
Placebo
n = 10
p (ANOVA)
Day -14 1,35 ± 0,48 1,34 ± 0,47 1,13 ± 0,36 0,46
Day 0 0,07 ± 0,07 0,15 ± 0,10 0,14 ± 0,09 0,17
Increment from 
day 1 to day 0
0,86 ± 0,48 0,63 ± 0,38 0,81 ± 0,30 0,4
Increment from 
day 7 to day 0
1,36 ± 0,58 0,61 ± 0,39* 1,44 ± 0,23 < 0,001
0,1%CHX-F
n = 10
0,12%CHX-A
n = 10
Placebo
n = 10
p
Staining (%) 30 40 20 0.8
Mucosal sensivities 
and/or Taste disturbance (%)
0 10 30 0.3
Table 1. Mean plaque index variation (± standard deviation) during the experimental period.
* Significant difference between 0.12% CLX and both 0.1% CLX and placebo (Tukey Post-Hoc analysis for multiple compari-
sons).
Table 2. Side effects noticed in each group during the study.
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Discussion
Chlorhexidine mouthrinses have been the most com-
mon antiseptic agents used in periodontology for many 
years. Their efficiency as a suitable anti plaque agent has 
been proved by several authors both in “in vitro” and 
“in vivo” studies. Several regimens have required rins-
ing with 10 ml volumes of 0.2% CLX , for one minute, 
twice daily (4,11,13). However, this concentration in-
duces tooth staining and taste aberration as local side 
effects (14). In order to reduce these side effects, dif-
ferent concentrations have been proposed. Thus, long-
term clinical trials have shown no evident differences 
between 0.1%, 0.12% and 0.2% CHLX mouthrinses as 
anti-plaque and anti-gingivitis agents (15-19).  
Our results indicate that, the 0.12% CLX-A mouthrins-
es resulted in considerably less plaque accumulation 
compared to diluted 0.1% CLX-F and the placebo. The 
same results were observed in a study of Addy et al. 
1991 (20) which compared the effect of 0.12% and 0.1% 
CHX mouthrinses on plaque accumulation and found 
that mean scores for plaque were predominantly lower 
with the 0.12% mouthrinse than with 0.1%.
These controversies can be explained either by the dose 
prescribed or the formulation of the mouthrinse. Indeed, 
the dose of CLX seems to be important on plaque inhi-
bition. Previous studies showed that the optimum dose 
of CLX is considered to be around 20mg twice daily; 
which balance the efficiency against local side effects 
and user acceptability (21-23). According to Keijser et 
al.,2003 (24), 0.12% CLX seems to be as effective as 
0.2% if the volume of rinse was increased from 10 to 
15 ml giving an 18mg dose on each occasion. Similar 
findings were reported by Smith et al (1995) (15) who 
showed that both 15 ml of 0.12% and 10 ml of 0.2% 
CLX have a significant efficiency against plaque accu-
mulation compared to the control.
It should be also mentioned that in our study, the volun-
teers in group 2 rinsed with 15ml of 0.10 CLX-F, but had 
been asked to use a third of mouthrinse with two thirds 
of water according to manufactures’ instructions. This 
reduces the concentration of the used CLX-F to 0.03% 
CLX solution; which can be probably the reason for the 
poorer efficacy. Indeed, the plaque inhibitory efficacy 
of Chlorhexidine is dose related with a dose –response 
curve being significantly flat above doses of 5-6mg 
twice per day (Jenkins et al., 1994) (23). 
Beside the concentration and the dose of Chlorhexidine 
mouthrinse, its formulation also influences the effi-
ciency (25). Many chemical agents have been added to 
mouthrinse solutions like alcohol, Sodium fluoride, and 
Cetyl Peridium Chloride. Among these agents, alcohol 
is widely used as an antiseptic agent itself and as a dis-
solvent of other ingredients. 
In this study 0.10% CLX-F (non alcohol) seems to be less 
efficient than the standard alcohol-containing chlorhex-
idine. This could be interpreted as CLX-A mouthrinses 
have slightly better anti plaque and anti gingivitis ef-
fects than CLX-F. 
However, it should be remembered that CLX-non alco-
hol mouthrinses would favour continual plaque reduc-
tion and can be preferably used when there is intolerance 
to Alcohol. Indeed, many studies have shown an effec-
tiveness of alcohol –free mouthrinse solutions in reduc-
ing plaque accumulation regarding to a placebo (16, 
26-27). In our study, the added component to the 0.1% 
CLX-non alcohol mouth rinse is Formaldehyde. This is 
an antiseptic agent widely used in endodontic product. 
However, its effect as an anti-plaque agent is not clear. 
Barnett et al. (2003) (28) had already pointed out, that 
the existence of a known substance (in this case, the 
chlorhexidine) does not guarantee activity and does not 
tell anything about its real action against plaque in vivo. 
This is mainly due to potential interactions-negative or 
positive ones- between the different components in a 
mouthrinse preparation.
Finally, in the present study, some side effects were re-
ported by participants about taste perception and mouth 
burning during and after rinsing with the 0.12% CLX al-
cohol base solution. This is probably due to alcohol con-
tained in the solution. Bolanowski et al. (1995) (29) found 
that an alcohol-containing CLX mouth rinse might even 
disturb the taste perception for many hours after rinsing 
(up to 4hours). Stains was also noticed in some subjects 
using either diluted 0.1% CLX-F or 0.12% CLX-A. This 
has been noted in the literature as an unwanted but com-
mon adverse event with the use of chlorhexidine mouth 
rinses. Lower dose or concentration does like standard 
0.12% alcohol or non alcohol-containing CLX mouthrinse 
appears to provide little benefit to reduce dental staining 
(Francis et al., 1987) (30).
The use of the 0.1% CLX solution with formaldehyde (al-
cohol-free) showed, only in one subject, some local irrita-
tions: red patches on the back of the tongue, knowing that 
formaldehyde can prove to be irritating for tissues (31). 
The double blind, randomized controlled design of this 
study showed significant results. However, the lack of 
cross-over design is a limitation of the study.   
Conclusion
It can be concluded from this study that 0.12% CLX al-
cohol base mouthrinse is significantly more effective in 
inhibiting plaque than the diluted 0.1% CLX non-alco-
hol base containing formaldehyde mouthrinse.
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